S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
The Next Big Crisis Is Here (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
Is This The End of Capitalism? (Ad)
Italy's premier visits Libya for talks on energy, migration
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Is This The End of Capitalism? (Ad)
Japan firm opens whale meat vending machines to push sales
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
The Next Big Crisis Is Here (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
Is This The End of Capitalism? (Ad)
Italy's premier visits Libya for talks on energy, migration
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Is This The End of Capitalism? (Ad)
Japan firm opens whale meat vending machines to push sales
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
The Next Big Crisis Is Here (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
Is This The End of Capitalism? (Ad)
Italy's premier visits Libya for talks on energy, migration
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Is This The End of Capitalism? (Ad)
Japan firm opens whale meat vending machines to push sales
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
The Next Big Crisis Is Here (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
Is This The End of Capitalism? (Ad)
Italy's premier visits Libya for talks on energy, migration
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Is This The End of Capitalism? (Ad)
Japan firm opens whale meat vending machines to push sales
Online system to seek asylum in US is quickly overwhelmed
NASDAQ:CRBP

Corbus Pharmaceuticals - CRBP News Today

$0.14
0.00 (0.00%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.14
▼
$0.15
50-Day Range
$0.11
▼
$0.19
52-Week Range
$0.10
▼
$0.62
Volume
1.36 million shs
Average Volume
1.30 million shs
Market Capitalization
$18.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get Corbus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter.



CRBP Media Mentions By Week

CRBP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRBP
News Sentiment
▼
0.62

0.71
▲
Average
Medical
News Sentiment

CRBP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRBP Articles
This Week
▼
3

0
▲
CRBP Articles
Average Week

SourceHeadline
MarketBeat logoCorbus Pharmaceuticals (NASDAQ:CRBP) Receives New Coverage from Analysts at StockNews.com
americanbankingnews.com - January 28 at 6:34 AM
marketwatch.com logoCorbus Pharmaceuticals Holdings Inc. stock remains steady Tuesday, still outperforms market
marketwatch.com - January 24 at 8:47 PM
marketwatch.com logoCorbus Pharmaceuticals Holdings Inc. stock rises Thursday, outperforms market
marketwatch.com - December 15 at 8:09 PM
marketwatch.com logoCorbus Pharmaceuticals Holdings Inc. stock falls Wednesday, underperforms market
marketwatch.com - December 14 at 6:03 PM
finance.yahoo.com logoCorbus Presents Latest Preclinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
finance.yahoo.com - November 10 at 6:01 PM
finance.yahoo.com logoCorbus Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - November 8 at 8:32 AM
msn.com logoWhy Qualtrics International Shares Are Trading Sharply Higher; Here Are 23 Stocks Moving Premarket
msn.com - October 25 at 8:43 AM
finance.yahoo.com logoCorbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
finance.yahoo.com - October 14 at 8:11 AM
finance.yahoo.com logoCorbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of Directors
finance.yahoo.com - September 26 at 9:27 AM
finance.yahoo.com logoCorbus Presents First Pre-Clinical Data for CRB-913 at the European Association for the Study of Diabetes 2022 Annual Conference
finance.yahoo.com - September 22 at 10:08 AM
finance.yahoo.com logoCorbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference
finance.yahoo.com - September 12 at 7:59 AM
finance.yahoo.com logoCorbus Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - August 9 at 8:29 AM
finance.yahoo.com logoCorbus Pharmaceuticals Holdings, Inc. (CRBP)
finance.yahoo.com - August 6 at 10:20 PM
apnews.com logoCorbus Pharmaceuticals: Q1 Earnings Snapshot
apnews.com - May 10 at 11:38 AM
seekingalpha.com logoCorbus Pharmaceuticals GAAP EPS of -$0.08 beats by $0.01
seekingalpha.com - May 10 at 11:38 AM
markets.businessinsider.com logoCorbus Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
markets.businessinsider.com - May 10 at 11:38 AM
msn.com logoMarijuana Stock Movers For April 18, 2022
msn.com - April 18 at 5:44 PM
finance.yahoo.com logoCorbus Presents First Preclinical Data for CRB-601 at the American Association for Cancer Research (AACR) Annual Meeting
finance.yahoo.com - April 8 at 5:43 PM
marketwatch.com logoCorbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors
marketwatch.com - April 7 at 9:41 PM
msn.com logoCitius (CTXR) Posts Top-Line Data From Pivotal Lymphoma Study
msn.com - April 7 at 11:41 AM
msn.com logoCannabis Stock Gainers And Losers From April 5, 2022
msn.com - April 5 at 7:20 PM
marketwatch.com logoCorbus Pharmaceuticals Holdings Inc. stock falls Monday, underperforms market
marketwatch.com - April 4 at 6:56 PM
finance.yahoo.com logoCorbus Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference
finance.yahoo.com - March 11 at 8:42 AM
benzinga.com logoCorbus Pharmaceuticals: Q4 Earnings Insights
benzinga.com - March 8 at 10:29 AM
finance.yahoo.com logoCorbus Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Updates
finance.yahoo.com - March 8 at 10:29 AM
finance.yahoo.com logoAkari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer
finance.yahoo.com - March 2 at 7:39 AM
benzinga.com logoClever Leaves Expands Deal With Cannatrek In Australia Via $3.6M Sales Agreement To Include THC Flower
benzinga.com - February 15 at 10:58 PM
msn.com logoCannabis Stock Gainers And Losers From February 2, 2022
msn.com - February 2 at 6:53 PM
sg.finance.yahoo.com logoCRBP Jan 2023 2.500 call
sg.finance.yahoo.com - January 22 at 6:03 PM
benzinga.com logoMindset Pharma Teams Up With The McQuade Center To Develop 2 Families Of Novel Psychedelic Compounds
benzinga.com - January 21 at 8:56 PM
nasdaq.com logoCorbus Pharmaceuticals Holdings Inc Shares Near 52-Week Low - Market Mover
nasdaq.com - January 19 at 10:50 PM
msn.com logoCannabis Stock Gainers And Losers From January 12, 2022
msn.com - January 12 at 8:09 PM
msn.com logoCannabis Stock Gainers And Losers From January 6, 2022
msn.com - January 6 at 6:53 PM
finance.yahoo.com logoHere's Why You Should Hold Onto Acadia Healthcare (ACHC) Now
finance.yahoo.com - December 31 at 1:50 PM
msn.com logoAfter Plunging 29.4% in 4 Weeks, Here's Why the Trend Might Reverse for Corbus Pharmaceuticals (CRBP)
msn.com - December 29 at 11:24 AM
finance.yahoo.com logoDown 31.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Corbus Pharmaceuticals (CRBP)
finance.yahoo.com - December 7 at 2:20 PM
marketwatch.com logoCorbus Pharmaceuticals Holdings Inc. stock rises Friday, still underperforms market
marketwatch.com - November 13 at 8:34 AM
finance.yahoo.com logoCorbus Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
finance.yahoo.com - November 12 at 9:49 AM
marketwatch.com logoCorbus Pharmaceuticals Holdings Inc. stock outperforms market on strong trading day
marketwatch.com - November 8 at 8:08 PM
finance.yahoo.com logoWill Corbus Pharmaceuticals (CRBP) Report Negative Q3 Earnings? What You Should Know
finance.yahoo.com - November 2 at 7:58 PM
finance.yahoo.com logoCorbus Pharmaceuticals Completes $27.2 Million Registered Direct Offering
finance.yahoo.com - October 26 at 7:37 AM
finance.yahoo.com logouniQure Announces the Appointment of Rachelle Jacques to its Board of Directors
finance.yahoo.com - October 21 at 10:17 AM
finance.yahoo.com logoCould The Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - September 10 at 7:57 AM
benzinga.com logoRecap: Corbus Pharmaceuticals Q2 Earnings
benzinga.com - August 12 at 4:30 PM
finance.yahoo.com logoCorbus Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
finance.yahoo.com - August 12 at 4:30 PM
finance.yahoo.com logoCorbus Pharmaceuticals (CRBP) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 12 at 4:30 PM
finance.yahoo.com logoCorbus Pharmaceuticals (CRBP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - July 29 at 5:41 PM
nasdaq.com logoCorbus Pharmaceuticals Holdings, Inc. Common Stock (CRBP)
nasdaq.com - July 23 at 6:58 PM
bizjournals.com logoCorbus shares fall as autoimmune drug fails another late-stage trial
bizjournals.com - June 24 at 2:29 PM
markets.businessinsider.com logoCorbus Says DETERMINE Phase 3 Study Of Lenabasum Did Not Meet Primary Endpoint - Quick Facts
markets.businessinsider.com - June 24 at 9:28 AM
Get Corbus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:CRBP) was last updated on 1/28/2023 by MarketBeat.com Staff